In addition, several studies have identified the PRR as an emerging player in the regulation of lipid metabolism [8,14], suggesting that the PRR could be a potential novel target for the treatment of metabolic syndrome-related diseases, including non-alcoholic fatty liver. The gene discussed is ATP6AP2; the disease is non-alcoholic fatty liver.